피브리노겐 농축 제제 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

The global market for Fibrinogen Concentrate was estimated to be worth US$ 1260 million in 2024 and is forecast to a readjusted size of US$ 2562 million by 2031 with a CAGR of 10.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Fibrinogen Concentrate cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Fibrinogen concentrate is a high-purity plasma protein preparation derived from human plasma or produced through recombinant technology, with fibrinogen as its main component. It plays a crucial role in blood clotting, as fibrinogen is converted into fibrin by thrombin to form a blood clot and stop bleeding. Fibrinogen concentrate is primarily used to treat congenital or acquired fibrinogen deficiencies, manage bleeding during surgery or trauma, and address other conditions requiring rapid fibrinogen supplementation.

The market for fibrinogen concentrate is primarily driven by the increasing prevalence of bleeding disorders and surgical procedures that require rapid hemostasis, as well as growing awareness and adoption of targeted blood management therapies. Advances in plasma fractionation and recombinant technologies, along with rising demand for safer, pathogen-reduced, and high-purity blood products, are also fueling market growth. Additionally, an aging population, higher incidence of trauma and cardiovascular surgeries, and expansion of healthcare infrastructure in emerging regions contribute to the increasing demand for fibrinogen concentrate.

The major producers in the industry are CSL Behring, LFB Group and Shanghai RAAS Blood Products, whose revenue ratios in 2024 are 52%, 20% and 10% respectively.

This report aims to provide a comprehensive presentation of the global market for Fibrinogen Concentrate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fibrinogen Concentrate by region & country, by Type, and by Application.

The Fibrinogen Concentrate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibrinogen Concentrate.

Market Segmentation

By Company

• CSL Behring
• LFB Group
• Shanghai RAAS
• China Resources Boya Bio-pharmaceutical
• Hualan Biological Engineering
• Harbin Pacific Biopharmaceutical
• China Meheco Group
• Octapharma

Segment by Type

• Human Fibrinogen Concentrate
• Others

Segment by Application

• Surgical Procedures
• Congenital Fibrinogen Deficiency
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Fibrinogen Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Fibrinogen Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Fibrinogen Concentrate in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Fibrinogen Concentrate Product Introduction
• 1.2 Global Fibrinogen Concentrate Market Size Forecast
  • 1.2.1 Global Fibrinogen Concentrate Sales Value (2020-2031)
  • 1.2.2 Global Fibrinogen Concentrate Sales Volume (2020-2031)
  • 1.2.3 Global Fibrinogen Concentrate Sales Price (2020-2031)
• 1.3 Fibrinogen Concentrate Market Trends & Drivers
  • 1.3.1 Fibrinogen Concentrate Industry Trends
  • 1.3.2 Fibrinogen Concentrate Market Drivers & Opportunity
  • 1.3.3 Fibrinogen Concentrate Market Challenges
  • 1.3.4 Fibrinogen Concentrate Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Fibrinogen Concentrate Players Revenue Ranking (2024)
• 2.2 Global Fibrinogen Concentrate Revenue by Company (2020-2025)
• 2.3 Global Fibrinogen Concentrate Players Sales Volume Ranking (2024)
• 2.4 Global Fibrinogen Concentrate Sales Volume by Company Players (2020-2025)
• 2.5 Global Fibrinogen Concentrate Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Fibrinogen Concentrate Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Fibrinogen Concentrate Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Fibrinogen Concentrate
• 2.9 Fibrinogen Concentrate Market Competitive Analysis
  • 2.9.1 Fibrinogen Concentrate Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Fibrinogen Concentrate Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrinogen Concentrate as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Human Fibrinogen Concentrate
  • 3.1.2 Others
• 3.2 Global Fibrinogen Concentrate Sales Value by Type
  • 3.2.1 Global Fibrinogen Concentrate Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Fibrinogen Concentrate Sales Value, by Type (2020-2031)
  • 3.2.3 Global Fibrinogen Concentrate Sales Value, by Type (%) (2020-2031)
• 3.3 Global Fibrinogen Concentrate Sales Volume by Type
  • 3.3.1 Global Fibrinogen Concentrate Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Fibrinogen Concentrate Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Fibrinogen Concentrate Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Fibrinogen Concentrate Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Surgical Procedures
  • 4.1.2 Congenital Fibrinogen Deficiency
  • 4.1.3 Others
• 4.2 Global Fibrinogen Concentrate Sales Value by Application
  • 4.2.1 Global Fibrinogen Concentrate Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Fibrinogen Concentrate Sales Value, by Application (2020-2031)
  • 4.2.3 Global Fibrinogen Concentrate Sales Value, by Application (%) (2020-2031)
• 4.3 Global Fibrinogen Concentrate Sales Volume by Application
  • 4.3.1 Global Fibrinogen Concentrate Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Fibrinogen Concentrate Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Fibrinogen Concentrate Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Fibrinogen Concentrate Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Fibrinogen Concentrate Sales Value by Region
  • 5.1.1 Global Fibrinogen Concentrate Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Fibrinogen Concentrate Sales Value by Region (2020-2025)
  • 5.1.3 Global Fibrinogen Concentrate Sales Value by Region (2026-2031)
  • 5.1.4 Global Fibrinogen Concentrate Sales Value by Region (%), (2020-2031)
• 5.2 Global Fibrinogen Concentrate Sales Volume by Region
  • 5.2.1 Global Fibrinogen Concentrate Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Fibrinogen Concentrate Sales Volume by Region (2020-2025)
  • 5.2.3 Global Fibrinogen Concentrate Sales Volume by Region (2026-2031)
  • 5.2.4 Global Fibrinogen Concentrate Sales Volume by Region (%), (2020-2031)
• 5.3 Global Fibrinogen Concentrate Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Fibrinogen Concentrate Sales Value, 2020-2031
  • 5.4.2 North America Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Fibrinogen Concentrate Sales Value, 2020-2031
  • 5.5.2 Europe Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Fibrinogen Concentrate Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Fibrinogen Concentrate Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Fibrinogen Concentrate Sales Value, 2020-2031
  • 5.7.2 South America Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Fibrinogen Concentrate Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Fibrinogen Concentrate Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Fibrinogen Concentrate Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Fibrinogen Concentrate Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Fibrinogen Concentrate Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Fibrinogen Concentrate Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Fibrinogen Concentrate Sales Value, 2020-2031
  • 6.3.2 United States Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Fibrinogen Concentrate Sales Value, 2020-2031
  • 6.4.2 Europe Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Fibrinogen Concentrate Sales Value, 2020-2031
  • 6.5.2 China Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Fibrinogen Concentrate Sales Value, 2020-2031
  • 6.6.2 Japan Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Fibrinogen Concentrate Sales Value, 2020-2031
  • 6.7.2 South Korea Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Fibrinogen Concentrate Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Fibrinogen Concentrate Sales Value, 2020-2031
  • 6.9.2 India Fibrinogen Concentrate Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Fibrinogen Concentrate Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 CSL Behring
  • 7.1.1 CSL Behring Company Information
  • 7.1.2 CSL Behring Introduction and Business Overview
  • 7.1.3 CSL Behring Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 CSL Behring Fibrinogen Concentrate Product Offerings
  • 7.1.5 CSL Behring Recent Development
• 7.2 LFB Group
  • 7.2.1 LFB Group Company Information
  • 7.2.2 LFB Group Introduction and Business Overview
  • 7.2.3 LFB Group Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 LFB Group Fibrinogen Concentrate Product Offerings
  • 7.2.5 LFB Group Recent Development
• 7.3 Shanghai RAAS
  • 7.3.1 Shanghai RAAS Company Information
  • 7.3.2 Shanghai RAAS Introduction and Business Overview
  • 7.3.3 Shanghai RAAS Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Shanghai RAAS Fibrinogen Concentrate Product Offerings
  • 7.3.5 Shanghai RAAS Recent Development
• 7.4 China Resources Boya Bio-pharmaceutical
  • 7.4.1 China Resources Boya Bio-pharmaceutical Company Information
  • 7.4.2 China Resources Boya Bio-pharmaceutical Introduction and Business Overview
  • 7.4.3 China Resources Boya Bio-pharmaceutical Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 China Resources Boya Bio-pharmaceutical Fibrinogen Concentrate Product Offerings
  • 7.4.5 China Resources Boya Bio-pharmaceutical Recent Development
• 7.5 Hualan Biological Engineering
  • 7.5.1 Hualan Biological Engineering Company Information
  • 7.5.2 Hualan Biological Engineering Introduction and Business Overview
  • 7.5.3 Hualan Biological Engineering Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Hualan Biological Engineering Fibrinogen Concentrate Product Offerings
  • 7.5.5 Hualan Biological Engineering Recent Development
• 7.6 Harbin Pacific Biopharmaceutical
  • 7.6.1 Harbin Pacific Biopharmaceutical Company Information
  • 7.6.2 Harbin Pacific Biopharmaceutical Introduction and Business Overview
  • 7.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Concentrate Product Offerings
  • 7.6.5 Harbin Pacific Biopharmaceutical Recent Development
• 7.7 China Meheco Group
  • 7.7.1 China Meheco Group Company Information
  • 7.7.2 China Meheco Group Introduction and Business Overview
  • 7.7.3 China Meheco Group Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 China Meheco Group Fibrinogen Concentrate Product Offerings
  • 7.7.5 China Meheco Group Recent Development
• 7.8 Octapharma
  • 7.8.1 Octapharma Company Information
  • 7.8.2 Octapharma Introduction and Business Overview
  • 7.8.3 Octapharma Fibrinogen Concentrate Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Octapharma Fibrinogen Concentrate Product Offerings
  • 7.8.5 Octapharma Recent Development

8 Industry Chain Analysis

• 8.1 Fibrinogen Concentrate Industrial Chain
• 8.2 Fibrinogen Concentrate Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Fibrinogen Concentrate Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Fibrinogen Concentrate Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer